• Fri, March 24, 2017

by: WOPRAI

Kindred Healthcare Inc. (NYSE:KND), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re

by: WOPRAI

Intersections Inc. (NASDAQ:INTX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Repo

by: WOPRAI

PharMerica Corporation (NYSE:PMC), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Rep

by: WOPRAI

NCI, Inc. (NASDAQ:NCIT), Up By $2.16 (16.47%) After BUYINS.NET SqueezeTrigger Report Released on Thursday, March 16th 2017 at a

by: WOPRAI

Taylor Devices Inc. (NASDAQ:TAYD), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

WILC SqueezeTrigger Price is $6.07. There is $36,285 That Short Sellers Still Need To Cover.

by: WOPRAI

Profire Energy Inc. (NASDAQ:PFIE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

Determine Inc. (NASDAQ:DTRM), Up By $1.64 (79.14%) After BUYINS.NET SqueezeTrigger Report Released on Monday, March 20th 2017 a

by: WOPRAI

Grupo Aeroportuario del Sureste S.A.B. de C.V. (NYSE:ASR), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Condit

by: WOPRAI

Key Technology Inc. (NASDAQ:KTEC), Up By $0.90 (6.98%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, March 21st 2

by: WOPRAI

SAMG SqueezeTrigger Price is $13.88. There is $809,380 That Short Sellers Still Need To Cover.

by: WOPRAI

CRSP SqueezeTrigger Price is $18.08. There is $5,650,820 That Short Sellers Still Need To Cover.

by: WOPRAI

CBIO SqueezeTrigger Price is $1.54. There is $466,623 That Short Sellers Still Need To Cover.

by: WOPRAI

Gafisa S.A. (NYSE:GFA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. (NASDAQ:OMAB), Up After BUYINS.NET Report Predicted Stock Would Go Up Due T

by: WOPRAI

Rex Energy Corporation (NASDAQ:REXX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

by: WOPRAI

iRhythm Technologies (NASDAQ:IRTC), Up By $7.74 (26.00%) After BUYINS.NET SqueezeTrigger Report Released on Thursday, March 23r

by: WOPRAI

Community Health Systems Inc. (NYSE:CYH), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

by: WOPRAI

Micron Technology Inc. (NASDAQ:MU), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re

by: WOPRAI

Hornbeck Offshore Services Inc. (NYSE:HOS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined I

by: WOPRAI

Diversified Restaurant Holdings Inc. (NASDAQ:SAUC), Up By $0.84 (54.49%) After BUYINS.NET SqueezeTrigger Report Released on Thu

by: WOPRAI

SAH, PJT, TINY, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

SFS, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

O, BCRX, SABR, ANET, TTGT, FNGN, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

FMBH, ALKS, HNI, EWBC, SALM, ENV, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

EUO, JO, CRVP, PCRX, FRP, MYY Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

RWR, FEZ, STO, IYR, DEF, APEI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

MPW, GLP, SODA, CMG, HEES, XCO Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EXR, SNY, SNH, SKX, BBG, ZUMZ Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SYT, ENS, HURN, IDT, NRG, DVY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CSII, VGK, BBD, NNBR, PFG, FORR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

PGR Expected To Be Up Before Next Earnings Releases

by: WOPRAI

RHT Expected To Be Up After Next Earnings Releases

by: WOPRAI

FHN Expected To Be Down Before Next Earnings Releases

by: WOPRAI

SNX Expected To Be Down After Next Earnings Releases

by: WOPRAI

Peter Keith Downgraded (SPWH) to Hold on, Mar 24th, 2017

by: WOPRAI

Matthew Niknam Initiated (CCOI) at Strong Buy and Held Target at $48 on, Mar 24th, 2017

by: WOPRAI

Brian Brungardt Upgraded (BSM) to Strong Buy on, Mar 24th, 2017

by: WOPRAI

Randal Konik Upgraded (UAA) to Strong Buy on, Mar 24th, 2017

by: WOPRAI

Liana Moussatos Reiterated (ASND) at Buy with Increased Target to $34 on, Mar 24th, 2017

by: WOPRAI

Chris Shibutani Initiated (SNDX) at Buy on, Mar 24th, 2017

by: WOPRAI

Joseph Pantginis Reiterated (VSTM) at Strong Buy with Increased Target to $78 on, Mar 24th, 2017

by: WOPRAI

Joseph Spak Upgraded (ALV) to Hold on, Mar 24th, 2017

by: WOPRAI

Ivan Feinseth Initiated (AXP) at Hold on, Mar 24th, 2017

by: WOPRAI

Yuriy Vlasov Upgraded (AA) to Strong Buy and Increased Target to $40 on, Mar 24th, 2017

by: WOPRAI

Laura Martin Downgraded (AAPL) to Strong Buy and Increased Target to $41 on, Mar 24th, 2017

by: WOPRAI

Jeff Kvaal Maintained (AAPL) at Strong Buy with Increased Target to $41 on, Mar 24th, 2017

by: WOPRAI

Michael Nemeroff Upgraded (ADBE) to Buy and Increased Target to $150 on, Mar 24th, 2017

Liana Moussatos Reiterated (ASND) at Buy with Increased Target to $34 on, Mar 24th, 2017

Liana Moussatos of Wedbush, Reiterated "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $31 to $34 on, Mar 24th, 2017.

Liana has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Joseph Schwartz of "Leerink Swann" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, March 9th, 2017


This is the rating of the analyst that currently disagrees with Liana

  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017

Like: 👍